| Title | Olverembatinib in advanced succinate dehydrogenase-deficient gastrointestinal stromal tumors: phase 1b study and translational research (Transcriptome data) |
|---|---|
| Description | Transcriptome data of 7 patients in 'Olverembatinib in advanced succinate dehydrogenase-deficient gastrointestinal stromal tumors: phase 1b study and translational research'. |
| Organism | Homo sapiens |
| Data Type | Other Type of Genomic Data |
| Data Accessibility | Controlled-access |
| BioProject | PRJCA026539 |
| Release Date | 2025-12-03 |
| Submitter | Yifan Zhai (yzhai@ascentage.com) |
| Organization | Ascentage Pharma (Suzhou) Co., Ltd |
| Submission Date | 2025-08-25 |
The data cannot be downloaded as it has not yet been registered in the Human Genetic Resource Management Platform of MOST.
| File ID | File Title | Number/Samples | File Type | File Size | File Suffix | Download |
|---|---|---|---|---|---|---|
| OMIX011595-05 | The genomics data chart of 7 patients (SI)-Figure S2 | 1 | Other Type of Genomic Data | 17.4 KB | xlsx | Unavailable |
| Paper Title | Journal Name | Publish Time | Accession | Citing Type |
|---|---|---|---|---|
| Olverembatinib, a multikinase inhibitor that modulates lipid metabolism, in advanced succinate dehydrogenase-deficient gastrointestinal stromal tumors: a phase 1b study and translational research | Signal Transduction and Targeted Therapy | 2025-11 | OMIX015800 OMIX011595 OMIX011594 OMIX011593 OMIX011592 OMIX011431 OMIX011424 OMIX011422 OMIX011352 OMIX010350 OMIX010183 OMIX010075 OMIX006519 | Deposit |